Abstract
No public abstract is available from the verified source records.
Harutyun Stepanyan, Hamzeh Ghorbani, Mikhail Poghosyan, Margarita Danielyan, Arsen Minasyan, Arsen Hunanyan, Naira Hunanyan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid-modulating mechanisms
10.1007/s10048-025-00821-y · 2025
The proline-rich hypothalamic peptide is a modulator of functions of neurotrophins and neuronal activity in amyloid-induced neurodegeneration
10.1134/s1819712414010036 · 2014
Enhanced neuroprotection against Alzheimer’s disease by combining Inula viscosa with curcumin: an in vitro study
10.5114/aoms/201186 · 2025
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
10.1186/s13041-024-01118-1 · 2024
The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus
10.61186/jcbr.7.4.15 · 2023
Protein kinase C involvement in neuroprotective effects of thymol and carvacrol against toxicity induced by Amyloid-β in rat hippocampal neurons
10.32598/bcn.2021.666.2 · 2022
Modulation of amyloid-β 1-42 structure and toxicity by proline-rich whey peptides
10.1039/c2fo30111c · 2012
Treatment of Alzheimer’s disease: beyond symptomatic therapies
10.3390/ijms241813900 · 2023
Targeted drug delivery: amyloid beta targeting drugs, immunotherapy, anti-tau and aggregation inhibitor, microtubule-stabilizing, and neuroinflammation modulation
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
2025
Alzheimer's disease drug development pipeline: 2024
2024
The cause of Alzheimer’s disease: the theory of multipathology convergence to chronic neuronal stress
10.14336/ad.2021.0529 · 2022
Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for Alzheimer’s disease
10.1007/s12035-021-02612-6 · 2022
Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25–35 model of Alzheimer's disease
10.1016/j.jalz.2007.10.019 · 2008
Reimagining cholinergic therapy for Alzheimer’s disease
10.1093/brain/awac096 · 2022
Multi‐Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, challenges, and Limitations
10.1002/prp2.70131 · 2025
Icariin as a new potential drug in Alzheimer disease treatment–a review
10.26444/jpccr/114763 · 2019
The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer’s disease: therapeutic implications and future perspectives
10.3390/antiox11112167 · 2022
Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: evidence for Aβ25–35
10.1016/j.expneurol.2009.09.005 · 2010
Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer’s mice model
10.1038/s41598-025-13920-5 · 2025
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
10.1186/s12974-022-02613-9 · 2022
Voglibose attenuates amyloid beta–induced memory deficits in a rodent model: a potential Alzheimer’s therapy via Wnt signaling modulation
10.1007/s12035-025-05047-5 · 2025
Application of a histochemical method for detection of Ca2+ dependent acid phosphatase activity for studies of morpho-functional state of the cell structures in the rat brain
10.1134/s181971240804020x · 2008
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
10.1152/physrev.00030.2022 · 2024
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
10.1523/jneurosci.13-04-01676.1993 · 1993
Alzheimer’s disease: from immune homeostasis to neuroinflammatory condition
10.3390/ijms232113008 · 2022
Alzheimer's disease
10.1056/nejmra0909142 · 2010
Amyloid beta in aging and Alzheimer’s disease
10.3390/ijms232112924 · 2022
Emerging diagnostics and therapeutics for Alzheimer disease
10.1038/s41591-023-02505-2 · 2023
The amyloid hypothesis of Alzheimer's disease at 25 years
10.15252/emmm.201606210 · 2016
Aβ oligomers–a decade of discovery
10.1111/j.1471-4159.2006.04426.x · 2007
Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats
10.1016/j.brainresbull.2011.08.003 · 2011
No additional external references are available.